Home / Tamsulosin and Solifenacin / Czechia
CZ ATC G04CA53 · updated 2 Nov 2026
Tamsulosin and Solifenacin shortage in Czechia
Is there a Tamsulosin and Solifenacin shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Tamsulosin and Solifenacin product is reported short in Czechia. The company estimate for the return is 28 Feb 2027. Main reason: manufacturing problem.
Also short in Italy, Spain, Austria, Belgium. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | SOLIFENACIN/TAMSULOSIN TEVA 6MG/0,4MG 6MG/0,4MG TBL MRL 100 anticipated | Teva B.V., Haarlem | 14 Dec 2026 | 28 Feb 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.